Southard, Kaden M. https://orcid.org/0000-0002-5017-0687
Ardy, Rico C. https://orcid.org/0000-0003-4975-2177
Tang, Anran https://orcid.org/0009-0001-5962-178X
O’Sullivan, Deirdre D.
Metzner, Eli https://orcid.org/0000-0002-8957-9068
Guruvayurappan, Karthik https://orcid.org/0000-0003-3791-8387
Norman, Thomas M. https://orcid.org/0000-0002-3755-4379
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (GM140925)
Damon Runyon Cancer Research Foundation (AWD-GC-259296)
Damon Runyon Cancer Research Foundation (DRG-2462-22)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (HG012103)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM132083)
Article History
Received: 24 February 2025
Accepted: 27 June 2025
First Online: 6 August 2025
Competing interests
: T.M.N. is an author on US Patent No. 11,214,797B2, related to Perturb-seq. The remaining authors declare no competing interests.